Elevance Health, Inc. (LON:0HG8)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 48.86B |
| Revenue (ttm) | 138.14B |
| Net Income (ttm) | 3.91B |
| Shares Out | n/a |
| EPS (ttm) | 17.07 |
| PE Ratio | 12.49 |
| Forward PE | 9.77 |
| Dividend | 5.12 (1.73%) |
| Ex-Dividend Date | Jun 10, 2025 |
| Volume | 102 |
| Average Volume | 2,225 |
| Open | 294.09 |
| Previous Close | 291.52 |
| Day's Range | 291.82 - 296.88 |
| 52-Week Range | 273.50 - 567.38 |
| Beta | 0.59 |
| RSI | 42.82 |
| Earnings Date | Jul 16, 2025 |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial numbers in USD Financial StatementsNews
3 SWANs On Sale
Our focus for today includes BMY, REXR, and ELV. The trio offers a safe 4.2% dividend yield, an A- credit rating average, and a 27% weighted discount to fair value. Bristol-Myers Squibb possesses a li...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
Elevance Health's Options: A Look at What the Big Money is Thinking
Investors with a lot of money to spend have taken a bullish stance on Elevance Health (NYSE: ELV). And retail traders should know. We noticed this today when the trades showed up on publicly availabl...
Paul MacDonald's Top Picks: Stryker, Abbott Labs & Elevance Health
Paul MacDonald, Chief Investment Officer & Portfolio Manager at Harvest Portfolios Group, shares his top stock picks to watch in the market.
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence
INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company's boa...
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare Inc. (NYSE: MOH) missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector . Shares of Alignment H...
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare Inc. MOH missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector.
Elevance Health: CEO Buys As CareBridge Drives Strong Growth
Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults
INDIANAPOLIS--(BUSINESS WIRE)-- #DigitalHealth--Study by Elevance Health, UCI, in collaboration with Apple, highlights potential of digital health tools to reduce asthma burden in U.S. populations.
Elevance Health downgraded at Argus on profit margin pressure
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio ? Elevance Health, Inc. (NYSE: ELV) shares decreased 17.96% this week after the company lowered its f...
Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight
Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight
S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health Tumbles
Major U.S. equities indexes pushed higher Thursday as a report revealed an increase in retail sales in June, suggesting that consumer spending remains strong despite tariff concerns.
Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More
Major U.S. equities indexes were higher at midday Thursday in the wake of better-than-expected quarterly results from several major companies. The Dow, S&P 500, and Nasdaq all advanced.
Centene Stock Hit A New 52-Week Low Today: What's Going On?
Shares of Centene Corp (NYSE: CNC) are trading lower on Thursday, hitting a new 52-week low, as worsening news from a key competitor intensified investor fears about the profitability of government-s...
Stocks making the biggest moves midday: Lucid Group, Elevance Health, Albemarle, PepsiCo & more
These are the stocks posting the largest moves midday.
Elevance Health outlines $30 EPS target for 2025 amid ACA and Medicaid cost pressures
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Elevance Health, Inc. 2025 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Elevance Health, Inc.
Elevance Health declares $1.71 dividend
Elevance Stock Falls After Earnings. What It Means for UnitedHealth, Other Insurers.
The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid.
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecas...
Earnings Snapshot: Elevance Health profit outlook misses estimates, stock drops
Elevance cuts annual profit forecast on high medical costs
Elevance lowered its annual profit forecast on Thursday as it expects elevated medical costs in its government-backed plans to persist, sending its shares 7% lower in premarket trading.
Elevance Health reports mixed Q2 results; updates FY25 outlook
Elevance Health (ELV) Q2 results: Non-GAAP EPS misses by $0.08; revenue up 14.3% YoY, beating estimates by $1.22B. FY 2025 EPS guidance revised.